Opinion Article
Safety of Prolonged Intraventricular Administration of Olistin Methanesulphonate
| Mairi Ziaka1, Demosthenes Makris1*, Sophia Markantonis2 and Epaminondas Zakynthinos1 | |
| 1Critical Care Department, University Hospital of Larissa, Larissa, Greece | |
| 2Laboratory of Biopharmaceutics and Pharmacokinetics, Faculty of Pharmacy, University of Athens, Greece | |
| *Corresponding Author : | Demosthenes Makris Department of Critical Care Medicine University Hospital of Larissa University of Thessaly School of Medicine Biopolis, Larisa 41000, Greece Tel: 302413502960 E-mail: dimomakris@med.uth.gr |
| Received: Mar 09, 2016 Accepted: Mar 16, 2016 Published: Mar 18, 2016 | |
| Citation: Ziaka M, Makris D, Markantonis S, Zakynthinos E (2016) Safety of Prolonged Intraventricular Administration of Olistin Methanesulphonate. J Neuroinfect Dis 7:207. doi:10.4172/2314-7326.1000207 | |
| Copyright: © 2016 Ziaka M, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. | |
